The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant|
by Fran Hawthorne (Author)
An in-depth look at big pharma's flagship company
The Merck Druggernaut takes readers inside Merck, the world's second most
profitable drug company and maker of the world's bestselling drug, Prilosec.
Consistently named one of Fortune magazine's Most Admired Companies, Merck
struggles to maintain its reputation for being the most ethical of the big drug
makers, refusing to slash research and development budgets in the face of
declining profits, falling stock market prices, and questionable accounting.
Author Fran Hawthorne, one of the leading journalists covering healthcare, has
written an excellent examination of a business paragon with much-needed insight
on the cutthroat world of pharmaceuticals. It's a story that will interest the
business world as well as consumer and healthcare advocates by detailing the
vital issues in medicine and healthcare today. More than just a compelling story
of success in a difficult industry, more than simply the biography of one of big
business's most recognizable names, The Merck Druggernaut takes a thoughtful
look at some of the major issues of our time and the way those issues intertwine
with the world of business.
Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New
York Business. She has been covering business for more than twenty years for
such publications as Fortune, BusinessWeek, and Institutional Investor, with a
prevailing interest in healthcare and pharmaceuticals. At Crain's, she
spearheads the publication of two to three special healthcare issues per year.
Paperback: 290 pages
Publisher: Wiley; 1 edition (February 14, 2005)